D. E. van der Kruijssen

Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients

C. Punt, M. Koopman, S. Elias, 2021, Digestive Surgery.

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival

I. Nagtegaal, R. Verhoeven, M. Koopman, 2019, Annals of Surgical Oncology.

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study

V. Velculescu, G. Meijer, R. Brosens, 2020, BMC Cancer.

Comparison between de novo and metachronous metastatic breast cancer: the presence of a primary tumour is not the only difference—a Dutch population-based study from 2008 to 2018

S. Siesling, E. van der Wall, S. Elias, 2023, Breast Cancer Research and Treatment.

Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer

C. Punt, R. Verhoeven, M. Koopman, 2021, American journal of clinical oncology.

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis

C. Punt, M. Koopman, S. Elias, 2022, International journal of cancer.

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.

C. Punt, M. Koopman, S. Elias, 2021, JAMA surgery.

Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply.

S. Elias, J. D. de Wilt, D. E. van der Kruijssen, 2022, JAMA surgery.